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Abstract
Background and Objectives: U-87 cells are one of the cell lines of glioblastoma tumors that
are used in most of the basic research in tumor studies. One of the coilrmon treaiments for this
tumor is chemotherapy, surgery, radiotherapy, etc. The main anticancer drugs include the
alkylating groups of DNA and anti-metabolites. The alkylating agents are also a diverse group
of chemical compounds capable of nucleic acid, proteiq molecular bands that inhibit
transcription or incomplete DNA transcription, and ultimately mutation causes cell death.
Platinum derivatives can be mentioned here. Carboplatin is one of the chemotherapy drugs for
the treatment of cancers, such as the brain, ovary and lung, and the use of magnetic field on
the U87 cell line induces apoptosis. According to previous studies, carboplatin induces cell
death in U-87 cells. Other magnetic fields also have different effects on cellular life and drug
performance. Due to the lack of a study on the simultaneous effect of carboplatin and
magnetic field on U-87 cells, the present study investigates the response of U-87 cells to
carbopiatin in the presence of magnetic field and the role of Caspase3 signaling molecule.
Methods: First, determination of the effective concentration of carboplatin on induction of U-
87 cell death was performed and then the results were used in the groups. Cells were seeded
in 6 groups (1: control 2: Drug, 3: frequency magnetic field, 4: static magnetic field, 5:
frequency- magnetic field and carboplatin, 6: Static magnetic field and carboplatin y).
Carboplatin and static and frequency magnetic fields were used. Finally, cell survival was
measured using MTT and protein expression using Western blot test.
Results: The results of this study showed that carboplatin with dose of lmg I ml, aft.er 24
hours caused IC50% in U-87 cells. On the other hand, the frequency magnetic field caused
death of U-87 cells after 24 b, but the static magnetic field did not have a significant effect on
any times surprisingly, coadministeration of carboplatin and a magnetic field after 24 hours
reduced the drug toxicity.
Cgnclusion: In this project our data demonstrated that EMF (50 H2,70 G) reduced the
cytotoxicity of Carboplatin on human glioblastoma U87 cells.since EMF reduced the
apoptotic effect of carboplatirq possibly through a redox regulation mechanisrr, this approach
may be useful for protection of another tissue of adverse side effects of chemotherapy .there
forthis approachhave two sides of coir, inthepositive side it ispossible increasing the dose
of drug in tumor area withoud any negative results because of applying magnetic field and in
negative side we have to avoid from coadminestration of magnetic field and Carboplatin in
tumor area , because magnetic field decreased toxicity of drug Further studies are needed to
finding mechanism of this possible novel therapeutic approach
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